• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结构不同的 HDAC 抑制剂对 、 、 和 的作用。

Effects of Structurally Different HDAC Inhibitors against , , and .

机构信息

Department of Drug Chemistry and Technologies, Sapienza University of Rome, P. le A. Moro 5, 00185 Rome, Italy.

Institute of Molecular Biology and Pathology, National Research Council (CNR), Via degli Apuli 4, 00185 Rome, Italy.

出版信息

ACS Infect Dis. 2022 Jul 8;8(7):1356-1366. doi: 10.1021/acsinfecdis.2c00232. Epub 2022 Jun 22.

DOI:10.1021/acsinfecdis.2c00232
PMID:35732073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9274761/
Abstract

Neglected tropical diseases (NTDs), including trypanosomiasis, leishmaniasis, and schistosomiasis, result in a significant burden in terms of morbidity and mortality worldwide every year. Current antiparasitic drugs suffer from several limitations such as toxicity, no efficacy toward all of the forms of the parasites' life cycle, and/or induction of resistance. Histone-modifying enzymes play a crucial role in parasite growth and survival; thus, the use of epigenetic drugs has been suggested as a strategy for the treatment of NTDs. We tested structurally different HDACi -, chosen from our in-house library or newly synthesized, against spp, and . Among them, emerged as the most potent against all of the tested parasites, but it was too toxic against host cells, hampering further studies. The retinoic 2'-aminoanilide was less potent than in all parasitic assays, but as its toxicity is considerably lower, it could be the starting structure for further development. In , compound exhibited a single-digit micromolar inhibition of parasite growth combined with moderate toxicity. In , 's close analogs - were tested in new transformed schistosomula (NTS) and adult worms displaying high death induction against both parasite forms. Among them, and exhibited very low toxicity in human retinal pigment epithelial (RPE) cells, thus being promising compounds for further optimization.

摘要

被忽视的热带病(NTDs),包括锥虫病、利什曼病和血吸虫病,每年在全球范围内都给发病率和死亡率带来了巨大的负担。目前的抗寄生虫药物存在多种局限性,如毒性、对寄生虫生命周期所有形式均无疗效和/或诱导耐药性。组蛋白修饰酶在寄生虫的生长和存活中起着至关重要的作用;因此,人们提出使用表观遗传药物作为治疗 NTDs 的一种策略。我们测试了结构不同的 HDACi - ,这些抑制剂是从我们的内部库中选择的或新合成的,针对 spp 和. 在这些抑制剂中, 对所有测试的寄生虫都表现出最强的活性,但对宿主细胞的毒性太大,阻碍了进一步的研究。维甲酸 2'-氨基苯甲酰胺 不如 在所有寄生虫检测中有效,但由于其毒性要低得多,它可能成为进一步开发的起始结构。在 中,化合物 对寄生虫生长的抑制作用在微摩尔范围内,同时具有中等毒性。在 中,测试了 的类似物 - ,它们对新转化的血吸虫(NTS)和成虫都有很高的致死诱导作用,对两种寄生虫形式都有很高的致死诱导作用。其中, 和 对人视网膜色素上皮(RPE)细胞的毒性非常低,因此是进一步优化的有前途的化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f2e/9274761/058887f3f8bf/id2c00232_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f2e/9274761/2df3c819ce9f/id2c00232_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f2e/9274761/1e98c99c8f0d/id2c00232_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f2e/9274761/058887f3f8bf/id2c00232_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f2e/9274761/2df3c819ce9f/id2c00232_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f2e/9274761/1e98c99c8f0d/id2c00232_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f2e/9274761/058887f3f8bf/id2c00232_0002.jpg

相似文献

1
Effects of Structurally Different HDAC Inhibitors against , , and .结构不同的 HDAC 抑制剂对 、 、 和 的作用。
ACS Infect Dis. 2022 Jul 8;8(7):1356-1366. doi: 10.1021/acsinfecdis.2c00232. Epub 2022 Jun 22.
2
Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.临床批准的组蛋白去乙酰化酶抑制剂对疟原虫、利什曼原虫和血吸虫寄生虫生长的影响。
Int J Parasitol Drugs Drug Resist. 2017 Apr;7(1):42-50. doi: 10.1016/j.ijpddr.2016.12.005. Epub 2016 Dec 23.
3
Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.探索对利什曼原虫和锥虫寄生虫具有抗原生动物活性的微藻和蓝藻代谢产物。
Acta Trop. 2024 Mar;251:107116. doi: 10.1016/j.actatropica.2023.107116. Epub 2023 Dec 28.
4
Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi.来自黄鹌菜的倍半萜内酯类化合物具有抗墨西哥利什曼原虫和克氏锥虫的活性。
Parasit Vectors. 2017 Nov 13;10(1):567. doi: 10.1186/s13071-017-2509-6.
5
Phenotypic Screening of Histone Deacetylase (HDAC) Inhibitors against Schistosoma mansoni.针对曼氏血吸虫的组蛋白去乙酰化酶(HDAC)抑制剂的表型筛选。
ChemMedChem. 2022 Sep 16;17(18):e202100622. doi: 10.1002/cmdc.202100622. Epub 2022 Aug 19.
6
The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection.宿主-寄生虫关系的对话:利什曼原虫属和克氏锥虫感染
Biomed Res Int. 2015;2015:324915. doi: 10.1155/2015/324915. Epub 2015 May 18.
7
Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production.鉴定新型多阶段组蛋白去乙酰化酶(HDAC)抑制剂,以损害曼氏血吸虫的生存能力和产卵。
Parasit Vectors. 2018 Dec 27;11(1):668. doi: 10.1186/s13071-018-3268-8.
8
Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages.化学多样性的曼氏血吸虫 HDAC8 抑制剂降低幼虫和成虫阶段的蠕虫活力。
ChemMedChem. 2023 Feb 1;18(3):e202200510. doi: 10.1002/cmdc.202200510. Epub 2022 Nov 8.
9
In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.芳基取代咪唑衍生物作为抗原生动物药物的体外评价以及对克氏锥虫、婴儿利什曼原虫和布氏锥虫的甾醇14α-脱甲基酶(CYP51)的对接研究。
Parasitol Res. 2019 May;118(5):1533-1548. doi: 10.1007/s00436-019-06206-z. Epub 2019 Mar 23.
10
Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy.抗氧化防御系统作为恰加斯病和利什曼病化疗的合理靶点。
Mem Inst Oswaldo Cruz. 2022 Feb 28;117:e210401. doi: 10.1590/0074-02760210401. eCollection 2022.

引用本文的文献

1
Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of .基于反苯环丙胺的赖氨酸特异性去甲基化酶1(LSD1)抑制剂作为降低……活力的有效药物
ACS Infect Dis. 2025 Aug 8;11(8):2178-2189. doi: 10.1021/acsinfecdis.5c00224. Epub 2025 Jul 2.
2
Histone Deacetylase Inhibitors Show a Potential Leishmanicidal Effect against Leishmania braziliensis in a Mouse Infection Model and Lead to Less Toxicity than Glucantime.在小鼠感染模型中,组蛋白去乙酰化酶抑制剂对巴西利什曼原虫显示出潜在的杀利什曼原虫作用,且比葡甲胺锑酸盐毒性更低。
ACS Omega. 2025 May 6;10(19):19466-19479. doi: 10.1021/acsomega.4c11381. eCollection 2025 May 20.
3

本文引用的文献

1
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis.用于治疗血吸虫病的组蛋白去乙酰化酶(HDAC)抑制剂
Pharmaceuticals (Basel). 2022 Jan 10;15(1):80. doi: 10.3390/ph15010080.
2
A potent HDAC inhibitor blocks Toxoplasma gondii tachyzoite growth and profoundly disrupts parasite gene expression.一种有效的组蛋白去乙酰化酶抑制剂可阻断刚地弓形虫速殖子的生长并严重扰乱寄生虫基因表达。
Int J Antimicrob Agents. 2022 Mar;59(3):106526. doi: 10.1016/j.ijantimicag.2022.106526. Epub 2022 Jan 15.
3
Species-selective targeting of pathogens revealed by the atypical structure and active site of Trypanosoma cruzi histone deacetylase DAC2.
Benign-by-Design SAHA Analogues for Human and Animal Vector-Borne Parasitic Diseases.
用于人类和动物媒介传播寄生虫病的设计良性SAHA类似物。
ACS Med Chem Lett. 2024 Aug 13;15(9):1506-1515. doi: 10.1021/acsmedchemlett.4c00242. eCollection 2024 Sep 12.
4
Theileria parasites sequester host eIF5A to escape elimination by host-mediated autophagy.泰勒虫寄生虫隔离宿主真核起始因子5A以逃避宿主介导的自噬清除。
Nat Commun. 2024 Mar 12;15(1):2235. doi: 10.1038/s41467-024-45022-7.
5
Advances in Protozoan Epigenetic Targets and Their Inhibitors for the Development of New Potential Drugs.原生动物表观遗传靶点及其抑制剂在新型潜在药物开发中的研究进展
Pharmaceuticals (Basel). 2023 Apr 4;16(4):543. doi: 10.3390/ph16040543.
6
Chemical Inhibition of Bromodomain Proteins in Insect-Stage African Trypanosomes Perturbs Silencing of the Variant Surface Glycoprotein Repertoire and Results in Widespread Changes in the Transcriptome.化学抑制昆虫期非洲锥虫的溴结构域蛋白会扰乱变体表面糖蛋白库的沉默,并导致转录组广泛变化。
Microbiol Spectr. 2023 Jun 15;11(3):e0014723. doi: 10.1128/spectrum.00147-23. Epub 2023 Apr 25.
7
Virtual Special Issue: Epigenetics 2022.虚拟特刊:2022年表观遗传学
ACS Pharmacol Transl Sci. 2022 Sep 9;5(10):829-834. doi: 10.1021/acsptsci.2c00169. eCollection 2022 Oct 14.
8
Virtual Special Issue: Epigenetics 2022.虚拟特刊:2022年表观遗传学
ACS Med Chem Lett. 2022 Oct 13;13(10):1524-1529. doi: 10.1021/acsmedchemlett.2c00393.
结构和活性位点均不典型的克氏锥虫组蛋白去乙酰化酶 DAC2,可实现对病原体的种属特异性靶向。
Cell Rep. 2021 Dec 21;37(12):110129. doi: 10.1016/j.celrep.2021.110129.
4
Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria.发现 FNDR-20123,一种组蛋白去乙酰化酶抑制剂,用于治疗恶性疟原虫疟疾。
Malar J. 2020 Oct 12;19(1):365. doi: 10.1186/s12936-020-03421-3.
5
Targeting histone acetylation/deacetylation in parasites: an update (2017-2020).靶向寄生虫中的组蛋白乙酰化/去乙酰化:最新进展(2017-2020 年)。
Curr Opin Chem Biol. 2020 Aug;57:65-74. doi: 10.1016/j.cbpa.2020.05.008. Epub 2020 Jun 29.
6
The Histone Deacetylase Inhibitor Entinostat/Syndax 275 in Osteosarcoma.组蛋白去乙酰化酶抑制剂恩替诺特/ Syndax 275 在骨肉瘤中的应用。
Adv Exp Med Biol. 2020;1257:75-83. doi: 10.1007/978-3-030-43032-0_7.
7
Screening and Phenotypical Characterization of Histone Deacetylase 8 (HDAC8) Inhibitors as Multistage Antischistosomal Agents.组蛋白去乙酰化酶8(HDAC8)抑制剂作为多阶段抗血吸虫药物的筛选及表型特征分析
ACS Infect Dis. 2020 Jan 10;6(1):100-113. doi: 10.1021/acsinfecdis.9b00224. Epub 2019 Nov 12.
8
Effects of the Environment on Developmental Plasticity and Infection Success of Parasites - An Epigenetic Perspective.环境对寄生虫发育可塑性和感染成功率的影响——表观遗传学视角
Front Microbiol. 2019 Jul 9;10:1475. doi: 10.3389/fmicb.2019.01475. eCollection 2019.
9
Heck Diversification of Indole-Based Substrates under Aqueous Conditions: From Indoles to Unprotected Halo-tryptophans and Halo-tryptophans in Natural Product Derivatives.水相条件下基于吲哚的底物的 Heck 多样化反应:从吲哚到天然产物衍生物中的未保护卤代色氨酸和卤代色氨酸
Chemistry. 2019 Aug 14;25(46):10866-10875. doi: 10.1002/chem.201901327. Epub 2019 Jul 19.
10
Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni.曼氏血吸虫早期药物发现的生命周期维持和药物敏感性测定。
Nat Protoc. 2019 Feb;14(2):461-481. doi: 10.1038/s41596-018-0101-y.